The Success of Warfarin Treatment for Coronary Thrombosis in a Young Patient With Acute Coronary Syndrome

2007 ◽  
Vol 15 (1) ◽  
pp. 117-118
Author(s):  
Ramazan Topsakal ◽  
Mehmet Gungor Kaya ◽  
Ibrahim Ozdogru ◽  
Mustafa Topuz ◽  
Tugrul Inanc ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Young Patient ◽  
Coronary Thrombosis ◽  
Coronary Syndrome ◽  
Warfarin Treatment

Atypical presentation of acute coronary syndrome in young patient

2014 ◽  
Vol 99 (792) ◽  
pp. 109-110
Author(s):  
María Sierra-Girón-Prieto ◽  
Gema García-Prieto ◽  
Margarita Martínez-Zaldivar-Moreno
Keyword(s):  
Acute Coronary Syndrome ◽  
Young Patient ◽  
Atypical Presentation ◽  
Coronary Syndrome

scholarly journals Patient with Acute Coronary Syndrome in the Setting of an Extremely Rare form of Complex Congenital Anomalous Coronaries

Aorta ◽  
2021 ◽  
Author(s):  
Mahmoud Abdelnabi ◽  
Fady Gerges ◽  
Yehia Saleh ◽  
Eman Elsharkawy ◽  
Mohamed Sanhoury ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Coronary Artery ◽  
Young Patient ◽  
Right Coronary Artery ◽  
Unusual Case ◽  
Single Coronary Artery ◽  
Sinus Of Valsalva ◽  
Rare Form ◽  
Coronary Syndrome ◽  
The Right

AbstractA single coronary artery is an exceedingly rare anomaly. Hereby, we present an unusual case of a young patient with an acute coronary syndrome who was found to have a single coronary artery originating from a single ostium in the right sinus of Valsalva with dual left anterior descending (LAD) arteries arising from the right coronary artery with two different anatomical courses, and additionally one of those LADs running a malignant intra-arterial course.

An unusual case of concurrent Kounis syndrome and prolonged QT in a young patient

2021 ◽  
pp. 1-3
Author(s):  
Emrah Erdogan ◽  
Murat Cap ◽  
Gorkem Kus ◽  
Cem Gokhan ◽  
Yakup Kilic
Keyword(s):  
Acute Coronary Syndrome ◽  
Young Patient ◽  
Unusual Case ◽  
Allergic Reactions ◽  
Kounis Syndrome ◽  
Unique Case ◽  
Coronary Syndrome ◽  
Life Threatening ◽  
Anaphylactoid Reactions ◽  
Prolonged Qt

Abstract Allergic reactions related to drug use is a common entity presenting often from minor urticaria to life-threatening anaphylactoid reactions. A common but easily overlooked diagnosis, Kounis syndrome, is an established hypersensitivity coronary disorder induced by drugs, foods, environmental factors, and coronary stents that can present in the same way as non-allergy-induced acute coronary syndrome. Here within, we present a unique case of dual presentation of Kounis syndrome and prolonged QTc in a young patient after a single dose of Domperidone and Lansoprazole.

PP-181 CORONARY BYPASS GRAFTING IN A YOUNG PATIENT WITH CORONARY DISSECTION ASSOCIATED ACUTE CORONARY SYNDROME

2013 ◽  
Vol 163 (3) ◽  
pp. S151
Author(s):  
F.G. Yesil ◽  
M. Tavlaşoglu ◽  
M. Kurkluoglu ◽  
Z. Arslan ◽  
A. Güler ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Young Patient ◽  
Coronary Bypass ◽  
Bypass Grafting ◽  
Coronary Bypass Grafting ◽  
Coronary Syndrome

PP-205 CORONARY SLOW FLOW IN A YOUNG PATIENT PRESENTED WITH ACUTE CORONARY SYNDROME

2012 ◽  
Vol 155 ◽  
pp. S168
Author(s):  
H. Yorgun ◽  
A.B. Nacar ◽  
A. Sökmen ◽  
G. Sökmen ◽  
C. Tuncer
Keyword(s):  
Acute Coronary Syndrome ◽  
Young Patient ◽  
Slow Flow ◽  
Coronary Syndrome ◽  
Coronary Slow Flow

scholarly journals Prevalence and Impact of Fibrinolytic Dysregulation in Patients with Acute Coronary Syndromes

2020 ◽  
Author(s):  
Huaibin Wan ◽  
Zhihao Wu ◽  
Zhenbang Lie ◽  
Daqiang Li ◽  
Shaohui Su
Keyword(s):  
Acute Coronary Syndrome ◽  
Cox Regression ◽  
Coronary Thrombosis ◽  
Major Adverse Cardiovascular Events ◽  
Prognostic Information ◽  
Cox Regression Analysis ◽  
Coronary Syndrome ◽  
Poor Outcomes ◽  
Fibrinolysis Shutdown

Abstract Background：Dual antiplatelet therapy can reduce coronary thrombosis and improve the prognosis in patients with acute coronary syndrome (ACS). However, there was limited prognostic information about fibrinolytic dysregulation in patients with ACS. This study is aimed to evaluated the prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndrome (ACS).Methods：We retrospectively analyzed coagulation and fibrinolysis related indexes of ACS in hospitalized adults with rapid thrombelastography between May 2016 and December 2018. All of the follow-up visits were ended by December 2019. The primary outcome was the occurrence of major adverse cardiovascular events (MACEs), which included unstable angina pectoris, non-fatal myocardial infarction, non-fatal cerebral infarction, heart failure and all-cause death. Results：338 patients were finally included with an average age of 62.5 ± 12.8 years old, 273 (80.5%) were males, 137(40.5%) patients were with STEMI. Fibrinolysis shutdown and hyperfibrinolysis were observed among 163 (48.2%) and 76(22.5%) patients, respectively. During a total of 603.2 person·years of follow-up period, 77 MACEs occurred (22.8%). Multivariate Cox regression analysis indicated that age [HR: 1.031 95% CI: 1.007-1.056, P = 0.012] and LY30 [HR: 1.097, 95% CI: 1.013-1.188, P = 0.023] were independently correlated with the occurrence of MACEs. The hazard ratios pertaining to MACEs in patients with LY30＜0.8% and ＞3.0% compared with those in the physiologic range(LY30: 0.8-3.0%) were 2.275 [HR: 2.275, 95% CI: 1.241-1.241, P = 0.003] and 1.196 [HR: 1.196, 95% CI: 0.679-2.109,P=0.535], respectively.Conclusions: Fibrinolytic dysregulation is very common in selected patients with ACS, and hyperfibrinolysis (HF) (LY30 >3%) is associated with poor outcomes in patients with ACS

scholarly journals Total coronary revascularisation in a young patient with acute coronary syndrome and multivessel disease.

2016 ◽  
Vol 11 (3-4) ◽  
pp. 104-104
Author(s):  
Zoran Miovski ◽  
Kristina Maric Besic ◽  
Maja Strozzi ◽  
Josko Bulum
Keyword(s):  
Acute Coronary Syndrome ◽  
Young Patient ◽  
Multivessel Disease ◽  
Coronary Revascularisation ◽  
Coronary Syndrome

scholarly journals Young Patient with Chagas Disease Presenting Initially as Acute Chest Pain and Treated for Acute Coronary Syndrome

2021 ◽  
Vol 34 (4) ◽  
Author(s):  
Jakson Ferreira Neto ◽  
◽  
Dannyl Roosevelt de Vasconcelos Lima ◽  
Pedro Vinicius Amorim de Medeiros Patriota ◽  
João Helbert Costa e Silva ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Chest Pain ◽  
Young Patient ◽  
Chagas Disease ◽  
Acute Chest Pain ◽  
Coronary Syndrome

Efficacy and safety of new oral anticoagulants as part of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome. Data from an observational study

Kardiologiia ◽  
2020 ◽  
Vol 60 (7) ◽  
pp. 53-63
Author(s):  
N. A. Sycheva ◽  
L. Yu. Koroleva ◽  
V. P. Nosov ◽  
G. V. Kovaleva ◽  
N. N. Paikova ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Acute Coronary Syndrome ◽  
Treatment Group ◽  
Antithrombotic Therapy ◽  
Oral Anticoagulants ◽  
Efficacy And Safety ◽  
Coronary Syndrome ◽  
Warfarin Treatment ◽  
Ischemic Events ◽  
Triple Antithrombotic Therapy

Aim To study efficacy and safety of a triple antithrombotic therapy with direct oral anticoagulants (DOAC) versus warfarin in patients with atrial fibrillation after acute coronary syndrome, for 12 months following discharge from the hospital.Materials and methods This single-site cohort, prospective, observational study performed at the Regional Vascular Center 2 of the N.A. Semashko Nizhniy Novgorod Regional Clinical Hospital included 402 patients. It was possible to maintain contacts with 206 patients for 12 months. These patients were divided into two groups, the DOAC treatment (n=105) and the warfarin treatment (n=101) as a part of triple antithrombotic therapy upon discharge. Clinical observation was performed at 1, 3, 6, and 12 months after the discharge by structured telephone interview. Predetermined efficacy endpoints included cardiovascular death, myocardial infarction, stent thrombosis, and ischemic stroke. Safety endpoints included bleeding defined as small, medium (clinically significant), and major in accordance with the TIMI classification.Results At 12 months of follow-up, 80 patients (76.19%) continued taking DOAC and 39 patients (38.61%, p<0.001) continued taking warfarin; in this process, only 25 patients (24.75%) monitored their INR on a regular basis. With a regular INR monitoring and TTR >70%, death rate did not differ in the warfarin and the DOAC treatment groups. However, there was a difference in reaching the composite efficacy endpoint (p=0.048): ischemic events occurred statistically significantly more frequently in the warfarin treatment group than in the DOAC treatment group.Conclusions In 12 months after discharge from the hospital, compliance with the DOAC treatment as a part of the antithrombotic therapy was significantly higher than compliance with the warfarin treatment. The triple antithrombotic therapy with DOAC was safer than the warfarin treatment by the number of hemorrhagic complications and more effective in prevention of ischemic events, primarily due to no need for monitoring of lab test values.

scholarly journals Coronary Artery Fistula Presenting as Unstable Angina Pectoris in Patients with Antiphospholipid Syndrome

2013 ◽  
Vol 2013 ◽  
pp. 1-3
Author(s):  
Şerafettin Demir ◽  
Ceyhun Yucel ◽  
Mucahit Tufenk ◽  
Aydin Rodi Tosu ◽  
Murat Selcuk ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Coronary Artery ◽  
Angina Pectoris ◽  
Unstable Angina ◽  
Cardiovascular System ◽  
Antiphospholipid Syndrome ◽  
Coronary Thrombosis ◽  
Coronary Artery Fistula ◽  
Patient Case ◽  
Coronary Syndrome

The cardiovascular system is one of the primary targets in patients with antiphospholipid syndrome. The valves are the most frequently affected. Atherosclerosis and coronary thrombosis are also seen. The risk of acute coronary syndrome is 10 times higher in patients with APS. We present an APS patient case who was hospitalized with acute coronary syndrome and who was later found to have coronary artery fistula.

Sign in / Sign up

Export Citation Format

Share Document